Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Inhaled Insulin (AERx) vs Insulin Aspart in Diabetes with Asthma
NCT00523042Phase 3Terminated
- Sponsor
- Novo Nordisk
- Start
- Aug 2007
- Primary completion
- Feb 2008
- Modality
- Biologic
- Countries
- 6
01
Overview
Phase 3, randomised, open-label trial of insulin human in type 1 diabetes mellitus (T1D) and type 2 diabetes mellitus (T2DM) (2 arms), sponsored by Novo Nordisk. Primary endpoints: Changes in lung function at 52 weeks, Changes in chest X-rays at 52 weeks and 1 more. Started Aug 2007; status: terminated.
02
Drugs
insulin human
03
Conditions
type 1 diabetes mellitus (T1D)type 2 diabetes mellitus (T2DM)
Beyond the preview
Go deeper on NCT00523042.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00523042.